Ad Millionaire Publishing
The 2:59 PM Trade
It's Friday afternoon, 2:59 pm. Most traders are clocking out. But legendary Millionaire trader Tim Sykes is about to cash in on a strange weekend "loophole."
He's used this exact method to make $8,780... $9,518... and even $16,159 over the weekend. But today, he wants to show YOU how to do it too.
By Nick Carey LONDON (Reuters) -A lack of data on electric vehicle (EV) batteries continues to challenge insurers who are forced to scrap EVs after mild accidents, potentially undermining EV adoption, Thatcham Research said on Wednesday. The British automotive risk intelligence company cited a “concerning lack of affordable or available repair solutions and post-accident diagnostics”…
LONDON (Reuters) – Almost one in three female workers in Britain expect to stop working before reaching their retirement age with many citing health and well-being issues including the menopause, according to a survey published on Wednesday. The British Standards Institution, which commissioned the survey, said the results showed the need for employers and the…
TOKYO (Reuters) -Japan is set to begin pumping out more than a million tonnes of treated water from the destroyed Fukushima Daiichi nuclear power plant this summer, a process that will take decades to complete. The water was distilled after being contaminated from contact with fuel rods at the reactor, destroyed in a 2011 earthquake….
By Emma Farge GENEVA (Reuters) -U.N. aid agencies on Tuesday voiced alarm at the scale of the ongoing Israeli military operation in the West Bank town of Jenin, where 10 Palestinians have been killed, saying there were restrictions on medical access. The operation, which involved drone strikes and hundreds of troops and was one of…
SEOUL (Reuters) – South Korea’s Samsung Biologics announced on Tuesday two deals with Pfizer worth around a combined 1.2 trillion won ($921.38 million) to manufacture products for the U.S. pharmaceutical giant. The latest deals will see the biotech division of the Samsung Group produce biosimilar products ranging from oncology and inflammation to immunotherapy in the…
By Daniel Trotta and Brendan Pierson (Reuters) – In state after state, conservative lawmakers this year have banned medical procedures for transgender youth. Now, a growing number of federal judges are blocking those laws from taking effect. U.S. district court judges have halted such laws in six states – Alabama, Arkansas, Florida, Indiana, Kentucky and…
By Nancy Lapid (Reuters) – The number of U.S. women who died within a year after pregnancy more than doubled between 1999 and 2019, with the highest deaths among Black women, researchers said on Monday. There were an estimated 1,210 maternal deaths in 2019, compared with 505 in 1999, according to a study published in…
By Maggie Fick and Ludwig Burger (Reuters) – AstraZeneca said on Monday an experimental precision drug slowed progression of lung cancer in a late-stage trial, but the company’s shares fell as much as 6% as analysts said the benefits may not be as pronounced as hoped. The drug, datopotamab deruxtecan, which is being jointly developed…
(Reuters) – Swiss drugmaker Sandoz said on Saturday it had launched a biosimilar version of AbbVie Inc’s big selling arthritis treatment Humira, adding to U.S. competition for the drug that started in January. The Novartis-owned company said its drug, Hyrimoz, will be priced at a 5% discount off Humira’s current list price of $6,922 per…
By Brendan O’Brien CHICAGO (Reuters) – Half of the U.S. population was urged on Friday to take precautions when they are outdoors, either due to a relentless heat wave or poor air quality caused by Canadian wildfires ahead of the long Fourth of July weekend. Some 80 million people living in California, the Deep South…
